New Study Finds Relationship Between Fibromylagia and Autonomic Dysfunction; Suggests New Treatment Options

A recent study published in the Journal of Clinical Rheumatology explores the connection between fibromyalgia and sympathetic nervous system dysfunction. This meta-study found that 65% of case-control studies found in the PubMed and EMBASE databases described “sympathetic nervous system predominance” as the “common clustering underlying pathogenesis”¹, meaning that the onset of symptoms like fatigue, irritable bowel syndrome, and interstitial cystitis are attributable to dysfunction within the autonomic nervous system.

For patients seeking relief from the debilitating symptoms of fibromyalgia, the implications of this study are profound. While traditional treatments have been primarily palliative and focused on pain relief, the authors of the study concluded that “it may be worth exploring the use of nonpharmacological measures as well as drug therapies aimed to regain autonomic balance”¹.

One such nonpharmacological treatment has been developed by doctors at Synergy Health in Newport Beach, California. The procedure, known as TVAM (transvascular autonomic modulation), has been successful in treating autonomic dysfunction in patients with fibromyalgia and other conditions. TVAM is a minimally invasive endovascular procedure that seeks to ‘reset’ the autonomic nervous system and restore balance to the body. The procedure itself takes about an hour, and involves threading a catheter with a small balloon through the central veins and stimulating the autonomic nerve fibers that run alongside them. An initial assessment and safety study performed at Synergy Health found that of 131 patients, there were “0 acute adverse events” and a “100% technical success rate².

Candidates for the TVAM procedure undergo QSART (sweat testing) and HRV (heart rate variability) testing to screen for the presence of autonomic dysfunction³. Results of the treatment are immediate, with 90% of patients experiencing a dramatic reduction in symptoms during and directly following the procedure⁴. Improvements have shown to be been long-lasting in 75% of patients, some continuing to maintain or improve 2-3 years after treatment.

For more information on the TVAM procedure or to find out about QSART and HRV testing for autonomic dysfunction, contact Synergy Health via web form or call (877) 792-2784.

¹http://www.ncbi.nlm.nih.gov/m/pubmed/24662556/
²http://www.synergyhealthconcepts.com/venous-transvascular-autonomic-modulation-initial-assessment-and-safety/
³http://www.synergyhealthconcepts.com/heart-rate-variability-response-to-jugular-ballooning-in-patients-with-symptomatic-autonomic-dysfunction/
⁴http://www.synergyhealthconcepts.com/progressive-improvement-in-quality-of-life-after-jugular-balloon-dilation-in-patients-with-autonomic-dysfunction/

Comments

comments

Powered by Facebook Comments